Expression and function of Flt3/flk2 in human tumor cell lines

International Journal of Oncology

Volumn 14, Issue 4, 1999, Pages 765-770

  Serve, Hubert ^a,b   Flesch, Katharina ^a   Serve, Susanne ^a   Fenski, Regina ^a   Berdel, Wolfgang E ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cell surface receptor; Flt3; Receptor tyrosine kinase; Tyrosine phosphorylation

Indexed keywords

CD135 ANTIGEN; FLT3 PROTEIN, HUMAN; MESSENGER RNA; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; BLOOD DISEASE; CELL CULTURE; CELL DIVISION; CELL LINE; HUMAN; LEUKEMIA; LYMPHOMA; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; CELL DIVISION; CELL LINE; FMS-LIKE TYROSINE KINASE 3; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA; LYMPHOMA; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 0033111943     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.4.765     Document Type: Article

References (34)

1. Rosnet O, Schiff C, Pebusque MJ, Marchetto S, Tonnelle C, Toiron Y, Birg F and Birnbaum D: Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82: 1110-1119, 1993.
2. Rosnet O, Marchetto S, de Lapeyriere O and Birnbaum D: Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene 6: 1641-1650, 1991.
3. Matthews W, Jordan CT, Wiegand GW, Pardoll D and Lemischka IR: A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65: 1143-1152, 1991.
4. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91: 459-463, 1994.
5. Lyman SD, James L, Vanden Bos T, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, et al: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75: 1157-1167, 1993.
6. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP and McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 83: 2795-2801, 1994.
7. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, et al: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates crowth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368: 643-648, 1994.
8. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP and Lemischka IR: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3: 147-161, 1995.
9. Rasko JE, Metcalf D, Rossner MT, Begley CG and Nicola NA: The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 9: 2058-2066, 1995.
10. + hematopoietic progenitor cells. Blood 86: 3413-3420, 1995.
11. + bone marrow progenitor cells in vitro. Blood 87: 1317-1325, 1996.
12. Veiby OP, Lyman SD and Jacobsen SE: Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Blood 88: 1256-1265, 1996.
13. Namikawa R, Muench MO, de Vries JE and Roncarolo MG: The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 87: 1881-1890, 1996.
14. Hunte BE, Hudak S, Campbell D, Xu Y and Rennick D: flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J Immunol 156: 489-496, 1996.
15. Hirayama F, Lyman SD, Clark SC and Ogawa M: The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood 85: 1762-1768, 1995.
16. Muench MO, Roncarolo MG, Menon S, Xu Y, Kastelein R, Zurawski S, Hannum CH, Culpepper J, Lee F and Namikawa R: FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 85: 963-972, 1995.
17. - cells and maintains progenitor cells in vitro. Blood 87: 3563-3570, 1996.
18. Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D, Arnoulet C, Chabannon C, Kanz L, Hannum C and Birnbaum D: Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 10: 238-248, 1996.
19. Birg F, Courcoul M, Rosnet O, Bardin F, Pebusque MJ, Marchetto S, Tabilio A, Mannoni P and Birnbaum D: Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 80: 2584-2593, 1992.
20. Dehmel U, Zaborski M, Meierhoff G, Rosnet O, Birnbaum D, Ludwig WD, Quentmeier H and Drexler HG: Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells. Leukemia 10: 261-270, 1996.
21. Lisovsky M, Braun SE, Ge Y, Takahira H, Lu L, Savchenko VG, Lyman SD and Broxmeyer HE: Flt3-ligand production by human bone marrow stromal cells. Leukemia 10: 1012-1018, 1996.
22. Piacibello W, Fubini L, Sanavio F, Brizzi MF, Severino A, Garetto L, Stacchini A, Pegoraro L and Aglietta M: Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors. Blood 86: 4105-4114, 1995.
23. Berdel WE, Danhauser-Riedl S, Steinhauser G and Winton E: Various human hematopoietic growth factors (Interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73: 80-83, 1989.
24. Papadimitriou CA, Topp MS, Serve H, Oelmann E, Koenigsmann M, Maurer J, Oberberg D, Reufi B, Thiel E and Berdel WE: Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines. Eur J Cancer 31A: 2371-2378, 1995.
25. Serve H, Oelmann E, Herweg A, Oberberg D, Serve S, Reufi B, Mücke C, Minty A, Thiel E and Berdel WE: Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Cancer Res 56: 3583-3588, 1996.
26. Brasel K, McKenna HJ, Morrissey PJ, Charrier K, Morris AE, Lee CC, Williams DE and Lyman SD: Hematologic effects of flt3 ligand in vivo in mice. Blood 88: 2004-2012, 1996.
27. Maroc N, Rottapel R, Rosnet O, Marchetto S, Lavezzi C, Mannoni P, Birnbaum D and Dubreuil P: Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene 8: 909-918, 1993.
28. Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, Sonoda Y, Fujimoto T and Misawa S: Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 10: 1911-1918, 1996.
29. Berdel WE, de Vos S, Maurer J, Oberberg D, von Marschall Z, Schroeder JK, Li J, Ludwig W-D, Kreuser ED, Thiel E and Herrmann F: Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. Cancer Res 52: 3498-3502, 1992.
30. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG and Broudy VC: Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80: 374-381, 1992.
31. Kondoh G, Hayasaka N, Li Q, Nishimune Y and Hakura A: An in vivo model for receptor tyrosine kinase autocrine/paracrine activation: auto-stimulated KIT receptor acts as a tumor promoting factor in papillomavirus-induced tumorigenesis. Oncogene 10: 341-347, 1995.
32. Li Q, Kondoh G, Inafuku S, Nishimune Y and Hakura A: Abrogation of c-kit/Steel factor-dependent tumorigenesis by kinase defective mutants of the c-kit receptor: c-kit kinase defective mutants as candidate tools for cancer gene therapy. Cancer Res 56: 4343-4346, 1996.
33. Yokota S, Kiyoi H, Nakao M, Iwai T, Misawa S, Okuda T, Sonoda Y, Abe T, Kahsima K, Matsuo Y and Naoe T: Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Leukemia 11: 1605-1609, 1997.
34. Kiyoi H, Towatari M, Yokota S, Hamaguchi M, Ohno R, Saito H and Naoe T: Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 12: 1333-1337, 1998.